We have two marketed products, approved in the U.S. and Europe.
Approved in the United States, European Union, U.K. and Switzerland.
Please see full U.S. Prescribing Information for NEXLIZET.
U.S. healthcare professionals, or more information, please visit NEXLIZETHCP.com.
To learn more about the bempedoic acid and ezetimibe combination in Europe, visit our partner Daiichi-Sankyo Europe.